Published in Blood on March 02, 2011
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles (2013) 4.05
Heparin modulates the conformation and signaling of platelet integrin αIIbβ3. Thromb Res (2011) 1.39
Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg (2013) 1.02
KSHV attachment and entry are dependent on αVβ3 integrin localized to specific cell surface microdomains and do not correlate with the presence of heparan sulfate. Virology (2014) 0.82
Increased platelet reactivity in idiopathic pulmonary fibrosis is mediated by a plasma factor. PLoS One (2014) 0.80
Frequency of heparin/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity. Clin Res Cardiol (2012) 0.77
Platelet activation by heparin. Blood (2011) 0.77
Integrin αIIbβ3 transmembrane domain separation mediates bi-directional signaling across the plasma membrane. PLoS One (2015) 0.76
Platelet function in stored heparinised autologous blood is not superior to in patient platelet function during routine cardiopulmonary bypass. PLoS One (2012) 0.75
Plasma Kallikrein enhances platelet aggregation response by subthreshold doses of ADP. Biochimie (2017) 0.75
Modular GAG-matrices to promote mammary epithelial morphogenesis in vitro. Biomaterials (2016) 0.75
Low-Dose Heparin Anticoagulation During Extracorporeal Life Support for Acute Respiratory Distress Syndrome in Conscious Sheep. Shock (2015) 0.75
Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol (1994) 7.53
Focal adhesion kinase: the first ten years. J Cell Sci (2003) 6.83
Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med (2008) 3.16
Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circulation (1998) 2.72
The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood (2008) 2.22
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Lancet (1998) 2.06
Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res (2002) 1.76
Heparin-binding domains in vascular biology. Arterioscler Thromb Vasc Biol (2004) 1.71
Heparin modulates integrin function in human platelets. J Vasc Surg (2001) 1.62
Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications. Blood (2005) 1.59
A novel integrin-activated pathway forms PKB/Akt-stimulatory phosphatidylinositol 3,4-bisphosphate via phosphatidylinositol 3-phosphate in platelets. J Biol Chem (1998) 1.58
Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets. Blood (2008) 1.54
Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout. Blood (2007) 1.54
Tyrosine phosphorylation of pp125FAK in platelets requires coordinated signaling through integrin and agonist receptors. J Biol Chem (1994) 1.53
Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest (1980) 1.42
Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood (2001) 1.42
The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation. Blood (2007) 1.33
A method for purifying the platelet membrane glycoprotein IIb-IIIa complex. Anal Biochem (1985) 1.30
The temporal profile of the anti-PF4/heparin immune response. Blood (2008) 1.28
GSK3beta is a negative regulator of platelet function and thrombosis. Blood (2008) 1.27
Heparin-induced thrombocytopenia: a historical perspective. Blood (2008) 1.26
Molecular interplay between endostatin, integrins, and heparan sulfate. J Biol Chem (2009) 1.25
Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain. J Clin Invest (2009) 1.24
Exposure of acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by integrin alphaXbeta2. Proc Natl Acad Sci U S A (2005) 1.24
A heparin-binding domain of human von Willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J Biol Chem (1987) 1.14
Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation. Lancet (1982) 1.09
On the mechanism of platelet aggregation induced by heparin, protamine and polybrene. Scand J Haematol (1972) 1.06
Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators. Am J Cardiol (2000) 1.04
Heparin neutralization of PGI2: effects upon platelets. Science (1979) 1.01
Binding of platelet factor 4 to heparin oligosaccharides. Biochem J (1983) 0.96
Binding between the integrin alphaXbeta2 (CD11c/CD18) and heparin. J Biol Chem (2007) 0.95
Heparin binding is necessary, but not sufficient, for fibronectin aggregation. A fluorescence polarization study. J Biol Chem (1985) 0.95
Mechanistic basis of heparin-induced thrombocytopenia. Semin Thorac Cardiovasc Surg (2005) 0.93
Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1. Arch Biochem Biophys (2000) 0.90
Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin. Am J Cardiol (2007) 0.90
Heparin-coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients. Circulation (2003) 0.88
Characterization of platelet binding of heparins and other glycosaminoglycans. Thromb Res (1988) 0.87
Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia. Am J Hematol (1998) 0.86
Antigen generation in heparin-associated thrombocytopenia: the nonimmunologic type and the immunologic type are closely linked in their pathogenesis. Semin Thromb Hemost (1995) 0.86
Effects of low-molecular-weight heparin on platelets as compared with commercial heparin. Res Exp Med (Berl) (1984) 0.82
The mechanism of heparin-induced platelet aggregation. Eur J Haematol (1989) 0.80
Heparin-coated cardiopulmonary bypass circuits: current status. Perfusion (2001) 0.80
Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis. Baillieres Clin Obstet Gynaecol (1997) 0.80
Certain high molecular weight heparin chains have high affinity for vitronectin. Arch Biochem Biophys (2001) 0.80
Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition. Biochemistry (2007) 0.79
Heparin binding to normal and abnormal platelets. Thromb Res (1988) 0.78
The cell surface receptor G6b, a member of the immunoglobulin superfamily, binds heparin. FEBS Lett (2005) 0.78
Effect of heparin on platelet aggregation inhibited by PGI2, trifluoperazine and verapamil. Thromb Res (1986) 0.78
Heparin-induced thrombocytopenia: advances in diagnosis and treatment. Crit Care Nurse (2006) 0.78
Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood (2004) 3.05
Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol (2003) 2.30
Site-specific effects of PECAM-1 on atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol (2008) 1.78
TRPV4-mediated endothelial Ca2+ influx and vasodilation in response to shear stress. Am J Physiol Heart Circ Physiol (2009) 1.76
High-throughput phosphotyrosine profiling using SH2 domains. Mol Cell (2007) 1.72
Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. Blood (2012) 1.72
Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. J Clin Invest (2006) 1.69
The cell-adhesion and signaling molecule PECAM-1 is a molecular mediator of resistance to genotoxic chemotherapy. Cancer Biol Ther (2006) 1.65
Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment. Blood (2003) 1.62
Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets. Blood (2008) 1.54
Platelet PECAM-1 inhibits thrombus formation in vivo. Blood (2005) 1.53
The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). J Biol Chem (2007) 1.53
GPIbα regulates platelet size by controlling the subcellular localization of filamin. Blood (2011) 1.45
Endothelial cell PECAM-1 confers protection against endotoxic shock. Am J Physiol Heart Circ Physiol (2004) 1.44
PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood (2003) 1.33
PECAM-1: conflicts of interest in inflammation. Life Sci (2010) 1.30
Tests of the extension and deadbolt models of integrin activation. J Biol Chem (2007) 1.28
Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain. J Clin Invest (2009) 1.24
Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A. Nat Commun (2013) 1.20
TCR stimulation drives cleavage and shedding of the ITIM receptor CD31. J Immunol (2010) 1.15
Drug-dependent clearance of human platelets in the NOD/scid mouse by antibodies from patients with drug-induced immune thrombocytopenia. Blood (2010) 1.11
Glanzmann thrombasthenia: state of the art and future directions. Semin Thromb Hemost (2013) 1.08
Peroxynitrite reduces the endothelium-derived hyperpolarizing factor component of coronary flow-mediated dilation in PECAM-1-knockout mice. Am J Physiol Regul Integr Comp Physiol (2005) 1.05
PECAM-1: regulator of endothelial junctional integrity. Cell Tissue Res (2014) 1.05
PECAM-1 negatively regulates GPIb/V/IX signaling in murine platelets. Blood (2003) 1.01
Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia. Blood (2005) 1.00
The alleles of PECAM-1. Gene (2006) 1.00
The highly modified microcin peptide plantazolicin is associated with nematicidal activity of Bacillus amyloliquefaciens FZB42. Appl Microbiol Biotechnol (2013) 0.99
Platelet signaling. Handb Exp Pharmacol (2012) 0.99
Paxillin family members function as Csk-binding proteins that regulate Lyn activity in human and murine platelets. Biochem J (2007) 0.98
Neutrophil transmigration mediated by the neutrophil-specific antigen CD177 is influenced by the endothelial S536N dimorphism of platelet endothelial cell adhesion molecule-1. J Immunol (2010) 0.98
High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombasthenia. Blood (2013) 0.98
The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis. Am J Physiol Gastrointest Liver Physiol (2007) 0.97
Palmitoylation at Cys595 is essential for PECAM-1 localisation into membrane microdomains and for efficient PECAM-1-mediated cytoprotection. Thromb Haemost (2006) 0.97
Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity. J Cell Sci (2011) 0.96
Residues within a lipid-associated segment of the PECAM-1 cytoplasmic domain are susceptible to inducible, sequential phosphorylation. Blood (2011) 0.95
Lyn and PECAM-1 function as interdependent inhibitors of platelet aggregation. Blood (2011) 0.95
A newly identified complex of spinophilin and the tyrosine phosphatase, SHP-1, modulates platelet activation by regulating G protein-dependent signaling. Blood (2011) 0.93
Phospholipase Cgamma2 contributes to stable thrombus formation on VWF. FEBS Lett (2004) 0.93
Proteinase 3 contributes to transendothelial migration of NB1-positive neutrophils. J Immunol (2012) 0.93
Platelet gene therapy improves hemostatic function for integrin alphaIIbbeta3-deficient dogs. Proc Natl Acad Sci U S A (2011) 0.92
Inactivation of ompR promotes precocious swarming and flhDC expression in Xenorhabdus nematophila. J Bacteriol (2003) 0.92
Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia. Transfusion (2008) 0.92
Mapping early conformational changes in alphaIIb and beta3 during biogenesis reveals a potential mechanism for alphaIIbbeta3 adopting its bent conformation. Blood (2007) 0.92
Critical role for mouse marginal zone B cells in PF4/heparin antibody production. Blood (2013) 0.91
Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1. Biochemistry (2013) 0.91
Regulation of endothelial cell barrier function by antibody-driven affinity modulation of platelet endothelial cell adhesion molecule-1 (PECAM-1). J Biol Chem (2014) 0.90
An important role of phospholipase Cgamma1 in pre-B-cell development and allelic exclusion. EMBO J (2004) 0.90
Mechanisms of PECAM-1-mediated cytoprotection and implications for cancer cell survival. Leuk Lymphoma (2005) 0.89
Nitration of PECAM-1 ITIM tyrosines abrogates phosphorylation and SHP-2 binding. Biochem Biophys Res Commun (2002) 0.88
Reactive oxygen species induce reversible PECAM-1 tyrosine phosphorylation and SHP-2 binding. Am J Physiol Heart Circ Physiol (2003) 0.88
Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia. J Clin Invest (2008) 0.87
Arachidonic acid-induced dilation in human coronary arterioles: convergence of signaling mechanisms on endothelial TRPV4-mediated Ca2+ entry. J Am Heart Assoc (2013) 0.86
Platelet hyperreactivity explains the bleeding abnormality and macrothrombocytopenia in a murine model of sitosterolemia. Blood (2013) 0.86
Mechanism of outside-in {alpha}IIb{beta}3-mediated activation of human platelets by the colonizing Bacterium, Streptococcus gordonii. Arterioscler Thromb Vasc Biol (2010) 0.85
B-cell tolerance regulates production of antibodies causing heparin-induced thrombocytopenia. Blood (2013) 0.84
Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31). Curr Opin Hematol (2016) 0.83
An alternatively spliced isoform of PECAM-1 is expressed at high levels in human and murine tissues, and suggests a novel role for the C-terminus of PECAM-1 in cytoprotective signaling. J Cell Sci (2008) 0.83
The anti-inflammatory actions of platelet endothelial cell adhesion molecule-1 do not involve regulation of endothelial cell NF-kappa B. J Immunol (2010) 0.82